FDA Inspection
GenIbet Biopharmaceuticals, S.A.GenIbet Biopharmaceuticals, S.A. – FDA Inspection, Jan 31, 2023
Record Details
This FDA Inspection record concerns GenIbet Biopharmaceuticals, S.A., with an inspection on January 31, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a4db74d3-9f69-438f-9622-286f17aa8e56
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201486
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of GenIbet Biopharmaceuticals, S.A.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2025 | VAI | Office of Inspections and Investigations | Vaccine, Allergenic, and Live Biotherapeutic Products |
Other documents for GenIbet Biopharmaceuticals, S.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.